IMCD N.V. EO -,16/ NL0010801007 /
6/3/2024 3:31:22 PM | Chg. +0.450 | Volume | Bid6:20:14 PM | Ask6:20:14 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
138.800EUR | +0.33% | - Turnover: - |
138.450Bid Size: 40 | 139.850Ask Size: 40 | 7.95 bill.EUR | 1.60% | 27.21 |
GlobeNewswire
3/2/2022
Hillstream BioPharma R&D Day Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Ac...
GlobeNewswire
2/16/2022
Hillstream BioPharma Receives Orphan Drug Designation for HSB-1216 for the Treatment of Uveal Melano...
GlobeNewswire
3/18/2020
Ergomed Announces Provision of Clinical Research Services for COVID-19 Clinical Study
GlobeNewswire
1/13/2020
EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANT® ...
GlobeNewswire
2/28/2019
Adhesives - Global Market Analysis, Trends and Forecasts 2019: Outsourcing of Manufacturing Activity...
GlobeNewswire
11/16/2018
Asia Pacific Biopharma Excipients (Polyols, Solubilizers & Surfactants/Emulsifiers, Carbohydrates, S...
GlobeNewswire
9/26/2018
IMCD completes acquisition of European speciality chemicals distributor Velox
GlobeNewswire
8/1/2018
IMCD completes acquisition of US specialty chemicals distributor E.T. Horn Company
GlobeNewswire
3/5/2018
Nutraceutical Excipients Market Poised to Register 7.3% CAGR through 2026, globally - Future Market ...
GlobeNewswire
3/2/2018
IMCD to nominate Management Board and Supervisory Board members for (re)appointment
GlobeNewswire
2/8/2018
Adhesives Markets 2016-2024 by Volume & Value - Global Strategic Business Report 2017